SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 247,126.06 |
Enterprise Value ($M) | 272,606.06 |
Book Value ($M) | 40,805.00 |
Book Value / Share | 26.32 |
Price / Book | 6.06 |
NCAV ($M) | -39,962.00 |
NCAV / Share | -25.77 |
Price / NCAV | -6.18 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.09 |
Return on Assets (ROA) | 0.06 |
Return on Equity (ROE) | 0.17 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.71 |
Current Ratio | 0.93 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 24,155.00 |
Assets | 104,922.00 |
Liabilities | 64,117.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
AVRW – Avenir Wellness Solutions, Inc. | AVVH – AVVAA World Health Care Products, Inc. |
AXIM – AXIM Biotechnologies, Inc. | BCHMF – Bachem Holding AG |
BDPT – BioAdaptives, Inc. |
Financial data and stock pages provided by
Fintel.io